Invesco’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $46.3M | Buy |
244,763
+53,467
| +28% | +$9.34M | ﹤0.01% | 1101 |
|
|
2025
Q4 | $32.5M | Buy |
191,296
+20,090
| +12% | +$3.08M | ﹤0.01% | 1242 |
|
|
2025
Q3 | $22.6M | Sell |
171,206
-114,343
| -40% | -$13.7M | ﹤0.01% | 1403 |
|
|
2025
Q2 | $30.3M | Buy |
285,549
+56,009
| +24% | +$6.08M | 0.01% | 1257 |
|
|
2025
Q1 | $28.5M | Buy |
229,540
+24,060
| +12% | +$3.14M | 0.01% | 1274 |
|
|
2024
Q4 | $25.3M | Sell |
205,480
-55,493
| -21% | -$6.54M | ﹤0.01% | 1376 |
|
|
2024
Q3 | $29.1M | Sell |
260,973
-189,079
| -42% | -$20.7M | 0.01% | 1288 |
|
|
2024
Q2 | $48M | Buy |
450,052
+68,096
| +18% | +$7.49M | 0.01% | 1027 |
|
|
2024
Q1 | $46M | Sell |
381,956
-2,208
| -0.6% | -$270K | 0.01% | 1075 |
|
|
2023
Q4 | $47.3M | Sell |
384,164
-4,265
| -1% | -$532K | 0.01% | 1036 |
|
|
2023
Q3 | $50.3M | Sell |
388,429
-1,590
| -0.4% | -$212K | 0.01% | 952 |
|
|
2023
Q2 | $48.4M | Buy |
390,019
+126,836
| +48% | +$17.1M | 0.01% | 962 |
|
|
2023
Q1 | $38.5M | Buy |
263,183
+25,826
| +11% | +$3.82M | 0.01% | 1064 |
|
|
2022
Q4 | $37.8M | Buy |
237,357
+67,293
| +40% | +$9.86M | 0.01% | 1045 |
|
|
2022
Q3 | $22.7M | Sell |
170,064
-4,591
| -3% | -$698K | 0.01% | 1246 |
|
|
2022
Q2 | $27.2M | Buy |
174,655
+355
| +0.2% | +$54.6K | 0.01% | 1192 |
|
|
2022
Q1 | $27.1M | Sell |
174,300
-31,757
| -15% | -$4.61M | 0.01% | 1305 |
|
|
2021
Q4 | $26.3M | Sell |
206,057
-92,581
| -31% | -$12.2M | 0.01% | 1381 |
|
|
2021
Q3 | $38.9M | Buy |
298,638
+59,024
| +25% | +$8.92M | 0.01% | 1153 |
|
|
2021
Q2 | $42.6M | Sell |
239,614
-78,047
| -25% | -$13.5M | 0.01% | 1144 |
|
|
2021
Q1 | $52.2M | Sell |
317,661
-27,301
| -8% | -$4.49M | 0.01% | 1045 |
|
|
2020
Q4 | $56.9M | Buy |
344,962
+173,096
| +101% | +$25.8M | 0.02% | 978 |
|
|
2020
Q3 | $24.5M | Buy |
171,866
+16,572
| +11% | +$2.05M | 0.01% | 1211 |
|
|
2020
Q2 | $17.1M | Buy |
155,294
+50,304
| +48% | +$5.56M | 0.01% | 1345 |
|
|
2020
Q1 | $10.5M | Sell |
104,990
-44,184
| -30% | -$5.71M | ﹤0.01% | 1512 |
|
|
2019
Q4 | $22.3M | Sell |
149,174
-61,511
| -29% | -$8.37M | 0.01% | 1374 |
|
|
2019
Q3 | $27M | Sell |
210,685
-68,257
| -24% | -$9.15M | 0.01% | 1238 |
|
|
2019
Q2 | $39.8M | Buy |
278,942
+67,945
| +32% | +$9.13M | 0.01% | 1120 |
|
|
2019
Q1 | $30.2M | Buy |
210,997
+5,489
| +3% | +$716K | 0.01% | 1023 |
|
|
2018
Q4 | $25.5M | Buy |
205,508
+2,286
| +1% | +$339K | 0.01% | 1030 |
|
|
2018
Q3 | $34.2M | Sell |
203,222
-1,512
| -0.7% | -$260K | 0.01% | 990 |
|
|
2018
Q2 | $35.3M | Sell |
204,734
-27,105
| -12% | -$4.43M | 0.01% | 966 |
|
|
2018
Q1 | $35M | Sell |
231,839
-28,910
| -11% | -$4.24M | 0.01% | 896 |
|
|
2017
Q4 | $35.1M | Sell |
260,749
-30,737
| -11% | -$4.26M | 0.01% | 925 |
|
|
2017
Q3 | $42.6M | Sell |
291,486
-6,931
| -2% | -$1.05M | 0.02% | 847 |
|
|
2017
Q2 | $46.4M | Buy |
298,417
+35,242
| +13% | +$5.39M | 0.01% | 821 |
|
|
2017
Q1 | $38.2M | Sell |
263,175
-56,967
| -18% | -$7.42M | 0.01% | 910 |
|
|
2016
Q4 | $34.9M | Sell |
320,142
-13,846
| -4% | -$1.54M | 0.01% | 953 |
|
|
2016
Q3 | $40.6M | Sell |
333,988
-116,763
| -26% | -$15.7M | 0.01% | 861 |
|
|
2016
Q2 | $63.7M | Buy |
450,751
+109,090
| +32% | +$16.1M | 0.02% | 646 |
|
|
2016
Q1 | $44.6M | Sell |
341,661
-400,622
| -54% | -$49.9M | 0.02% | 798 |
|
|
2015
Q4 | $104M | Buy |
742,283
+54,602
| +8% | +$7.57M | 0.04% | 488 |
|
|
2015
Q3 | $91.3M | Sell |
687,681
-199,534
| -22% | -$34.4M | 0.04% | 509 |
|
|
2015
Q2 | $156M | Buy |
887,215
+104,384
| +13% | +$18.7M | 0.06% | 371 |
|
|
2015
Q1 | $135M | Buy |
782,831
+25,483
| +3% | +$4.37M | 0.05% | 423 |
|
|
2014
Q4 | $124M | Sell |
757,348
-8,062
| -1% | -$1.34M | 0.05% | 449 |
|
|
2014
Q3 | $123M | Buy |
765,410
+247,853
| +48% | +$38.1M | 0.05% | 441 |
|
|
2014
Q2 | $76.1M | Sell |
517,557
-318,644
| -38% | -$44.2M | 0.03% | 618 |
|
|
2014
Q1 | $116M | Sell |
836,201
-285,930
| -25% | -$43M | 0.05% | 457 |
|
|
2013
Q4 | $142M | Sell |
1,122,131
-145,143
| -11% | -$15M | 0.06% | 400 |
|
|
2013
Q3 | $117M | Buy |
1,267,274
+357,268
| +39% | +$28.8M | 0.05% | 420 |
|
|
2013
Q2 | $62.5M | Buy |
+910,006
| New | +$55.6M | 0.03% | 612 |
|
Other funds holding JAZZ
VPM
VCM
EC
Invesco's JAZZ Position: Q1 2026 in Review
Invesco increased its Jazz Pharmaceuticals (JAZZ) stake by 28% in Q1 2026, buying an estimated $9.34M and bringing the position to 244,763 shares worth $46.3M. The position accounts for ﹤0.01% of the portfolio, ranked #1101.
Invesco first reported a position in JAZZ in Q2 2013 and has held it in 52 quarters since. The position peaked at $156M in Q2 2015. 570 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.
- Invesco held 244,763 shares of Jazz Pharmaceuticals worth $46.3M as of Q1 2026.
- Invesco bought 53,467 Jazz Pharmaceuticals shares in Q1 2026, an estimated $9.34M.
- Jazz Pharmaceuticals made up ﹤0.01% of Invesco's portfolio in Q1 2026, its #1101 holding.
- Invesco first reported a position in Jazz Pharmaceuticals in Q2 2013 and has held it in 52 quarters since.
- Invesco's Jazz Pharmaceuticals position peaked at $156M in Q2 2015.
- 570 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.
Based on Invesco's 13F filing for Q1 2026, filed 12 May 2026.